Dr. Charles Abrams graduated from Johns Hopkins University and Yale University School of Medicine, and was elected to Phi Beta Kappa and Alpha Omega Alpha. After an internship at Temple University Hospital, followed by a residency and Hematology-Oncology fellowship at the University of Pennsylvania Hospital. He is currently a faculty member in the Department of Medicine at Penn, where he is the Vice-Chief for Research of the Hematology-Oncology Division.

Dr. Abrams’ research is focused on phospholipid adapator proteins and phospholipid kinases in the cytoskeletal dynamics of blood cells. Making extensive use of mouse genetics, his laboratory has given unique insight into signaling cascades essential for both normal hemostasis and perturbed during the generation of arterial thrombi. He is the Principal Investigator of two R01 awards, as well as the Project Leader in an NIH-supported Program Project. Dr. Abrams serves on the editorial boards of several journals including Blood, Thrombosis & Haemostasis, Thrombosis Research, and Current Opinions in Hematology. He has been elected to membership in the American Society of Clinical Investigation and the Association of American Physicians..

Dr. Abrams is Chair of the Hematology Board of the American Board of Internal Medicine, and is a member of their Board of Directors. He is Co-Chair of the NIH Center for Scientific Review (CSR) Hemostasis & Thrombosis (HT) Study Section, and previously served as Chair of the Review Committee on Thrombosis for the National Organization of the American Heart Association. Dr. Abrams was the Scientific Co-Chair of the 47th Annual Meeting of the American Society of Hematology (2005) and is currently Chair of the clinical platelet program at the upcoming 22nd Congress of the International Society on Thrombosis and Haemostasis (2009).

back to top